SCHEMBL95568

SCHEMBL95568

FC(F)(F)CCC[S]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL834857 0.90
SCHEMBL833677 0.87
SCHEMBL6054656 0.76
SCHEMBL8984071 0.76 ALOX15 (0.30)
Silver SCHEMBL32663029 0.72
SCHEMBL30140053 0.72 ALOX15 (0.33)
SCHEMBL4652997 0.72 ALOX15 (0.33)
SCHEMBL22821839 0.72 ALOX15 (0.33)
SCHEMBL726275 0.67
SCHEMBL30548959 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298872-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROIDAL RECEPTORS AND CALCIUM CHANNEL ACTIVITIES IRM LLC (BM) 2009-12-03 US claimed
EP-1828135-A4 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROIDAL RECEPTORS AND CALCIUM CHANNEL ACTIVITIES IRM LLC (BM) 2009-08-12 EP claimed
EP-1828135-A2 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROIDAL RECEPTORS AND CALCIUM CHANNEL ACTIVITIES IRM, LLC (BM) 2007-09-05 EP claimed
WO-2006066011-A2 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROIDAL RECEPTORS AND CALCIUM CHANNEL ACTIVITIES IRM LLC (BM) 2006-06-22 WO claimed
US-6828315-B1 Anti- inflammatories, anti-allergics, bronchodilatators, anti-asthmatics, or TNF alpha inhibitors WARNER-LAMBERT LLC 2004-12-07 US claimed
EP-3632441-B1 METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND DAY ONE BIOPHARMACEUTICALS INC (US) 2024-07-17 EP disclosed
EP-3782986-B1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2024-07-10 EP disclosed
US-20240217957-A1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-07-04 US disclosed
US-12024505-B2 Heterocyclic compounds useful as modulators of acetylcholine receptors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-07-02 US disclosed
US-12012419-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-06-18 US disclosed
WO-2024116086-A1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-06-06 WO disclosed
US-20240174677-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-05-30 US disclosed
US-4764534-A Anticoccidial naphthalenamines and combinations thereof ELI LILLY AND COMPANY (US) 1988-08-16 US disclosed
US-4683201-A Antibiotic A80190-producing Actinomadura oligospora and process ELI LILLY AND COMPANY (US) 1987-07-28 US disclosed
EP-0209971-A1 Polyether antibiotic and process for its production ELI LILLY AND COMPANY (US) 1987-01-28 EP disclosed
EP-0184291-A2 Polyether antibiotic A80190 ELI LILLY AND COMPANY (US) 1986-06-11 EP disclosed
US-4582822-A ANIMAL FEED ADDITIVES ELI LILLY AND COMPANY (US) 1986-04-15 US disclosed
EP-0102680-B1 SUBSTITUTED N-(2,4-DINITRO-6-(TRIFLUOROMETHYL)PHENYL)-NAPHTHALENAMINE DERIVATIVES ELI LILLY AND COMPANY (US) 1986-03-05 EP disclosed
EP-0102680-A1 Substituted N-(2,4-dinitro-6-(trifluoromethyl)phenyl)-naphthalenamine derivatives ELI LILLY AND COMPANY (US) 1984-03-14 EP disclosed
US-4423065-A MITICIDES, PARASITICIDES ELI LILLY AND COMPANY (US) 1983-12-27 US disclosed